Consume an Exogenous Ketones Drink Mix daily to evaluate its impact on anxiety levels.

• Weekly: Complete the Perceived Stress Scale (Past Week Version).
• Regularly: Complete the Depression, Anxiety and Stress Scales (DASS-21) Survey and General Anxiety Disorder (GAD-7) Scale.

The study titled "Stressed and Anxious? Will Exogenous Ketones Calm Your Nerves?" is an exploratory investigation aimed at evaluating the potential effects of a daily Exogenous Ketones Drink Mix on anxiety levels among adults experiencing mild to moderate anxiety. Conducted over a period of four weeks, this study represents a single-arm observational trial where participants serve as their own control group. At Efforia, this approach is termed a "Signal Phase" study, intended to provide an initial indication of positive outcomes that might be associated with the intervention. The study will utilize standardized assessment tools such as the Generalized Anxiety Disorder 7-item scale (GAD-7), the Perceived Stress Scale (Weekly version), and the Depression, Anxiety, and Stress Scales (DASS-21) to measure changes in anxiety and related mental health outcomes.

This research initiative is designed to address the burgeoning mental health crisis by assessing the efficacy of ketone supplements as a potentially effective and accessible intervention for anxiety relief. Participants will engage in a straightforward daily routine of consuming the Exogenous Ketones Drink Mix, while having internet access to facilitate survey completion and study participation. The study's findings are anticipated to provide directional indications of the supplement's effectiveness, which, if positive, could warrant further investigation through more rigorous research designs. Additionally, this Signal Phase study will contribute to a greater understanding of the safety profile of the supplement, as current safety data is limited.

Participants' experience in the study will be supported by comprehensive instructions and resources, including a personalized protocol schedule. They will be encouraged to integrate tools such as Google Calendar and Todoist to track their participation and ensure communication preferences are set to receive updates from Efforia. The study ensures participant confidentiality, with all data anonymized and used solely for research purposes. Should the results indicate a positive signal of the intervention's efficacy, this study could pave the way for more extensive trials (including on clinically relevant anxiety) and potentially reshape approaches to mental health management. For more detailed information, please refer to the "Minimal Risk Umbrella protocol."

The single-arm observational trial conducted under the Minimal Risk Citizen Science Umbrella Protocol aims to evaluate the effects of daily exogenous ketones on anxiety levels over an 8-week period. As with any study design, there are inherent limitations, particularly the absence of a control group, which can introduce biases and compromise the internal validity of the findings. In this study, bias is primarily managed through the use of an expectations questionnaire, which quantifies participant expectations and helps discern the extent to which self-reported improvements may be influenced by placebo effects or pre-existing beliefs about the benefits of exogenous ketones. By collecting this data, the study attempts to mitigate the impact of this bias, although it cannot be entirely eliminated.

The study's design further addresses potential biases and limitations by implementing a robust statistical methodology and considering stratification by participant demographics. This approach is crucial in a study where participants act as their own controls, as it allows for a more nuanced analysis of the data, taking into account variability across different groups. The careful design of the sample size ensures that the study is adequately powered to detect changes in anxiety, depression, and stress levels using well-established measures such as GAD-7, Perceived Stress Scale, and DASS-21. Despite the challenges associated with a single-arm trial, these strategies support the study's objective to bridge the gap between anecdotal evidence and scientific validation, contributing valuable insights into the potential of exogenous ketones as an alternative mental health intervention.

The trial's significance lies not only in its potential findings but also in its alignment with Efforia's goal of democratizing clinical research. By operating under the Minimal Risk Umbrella Protocol, the study supports research questions and researchers who might otherwise be overlooked, fostering an inclusive environment for citizen science. The use of exogenous ketones, a topic of growing interest yet limited rigorous investigation, exemplifies this mission. While the current study acts as a signal detection effort, identifying initial trends and outcomes, any positive findings will pave the way for more comprehensive studies with controlled and rigorous designs, further validating and elucidating the role of exogenous ketones in mental health. For more information on the protocol and its broader implications, individuals are encouraged to refer to the Minimal Risk Umbrella Protocol documentation.